scholarly article | Q13442814 |
P50 | author | Andrew Guy | Q56561942 |
James Beeson | Q56780488 | ||
Ivo Mueller | Q60043791 | ||
Peter M Siba | Q89223280 | ||
Paul A. Ramsland | Q38317548 | ||
P2093 | author name string | Jack S Richards | |
Vashti Irani | |||
P2860 | cites work | Localization of the 175-kilodalton erythrocyte binding antigen in micronemes of Plasmodium falciparum merozoites | Q68097055 |
Immune effector mechanisms in malaria | Q82383609 | ||
Acquired immunity to malaria | Q24651173 | ||
A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites | Q27230065 | ||
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175 | Q27678372 | ||
Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite | Q30043432 | ||
RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum. | Q30356310 | ||
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria | Q31169310 | ||
A family of erythrocyte binding proteins of malaria parasites | Q33198214 | ||
Defining childhood severe falciparum malaria for intervention studies | Q33294896 | ||
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic | Q34189972 | ||
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens | Q34209043 | ||
Critical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity. | Q34237880 | ||
An expanding ebl family of Plasmodium falciparum | Q34264741 | ||
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine | Q34937705 | ||
Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum | Q34988452 | ||
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria | Q35213495 | ||
Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya | Q35550197 | ||
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria | Q35569042 | ||
Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? | Q36391845 | ||
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
The risk of malarial infections and disease in Papua New Guinean children. | Q37088901 | ||
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway | Q37124750 | ||
Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity | Q37202344 | ||
The future for blood-stage vaccines against malaria | Q37471465 | ||
Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum | Q37969486 | ||
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya | Q39130334 | ||
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria | Q39362569 | ||
Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids | Q39515040 | ||
A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. | Q39516438 | ||
Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite | Q39600996 | ||
Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. | Q41460430 | ||
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages | Q41835030 | ||
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia | Q47954510 | ||
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum | Q48013061 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
antibody | Q79460 | ||
Plasmodium falciparum | Q311383 | ||
Plasmodium falciparum malaria | Q18554672 | ||
P304 | page(s) | 1244-1252 | |
P577 | publication date | 2015-07-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children | |
P478 | volume | 61 |
Q40102134 | Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion |
Q47347281 | Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII–V in Ghanaian children living in two communities with varying malaria transmission patterns |
Q47602559 | Beyond binding: antibody effector functions in infectious diseases. |
Q91918114 | Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives |
Q30386145 | Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy. |
Q44482507 | Editorial Commentary: Toward a Better Malaria Vaccine: Understanding How Antibodies to Malaria Protect Against Disease |
Q38650817 | Genetic evidence for erythrocyte receptor glycophorin B expression levels defining a dominant Plasmodium falciparum invasion pathway into human erythrocytes |
Q45944502 | Identification of immune signatures predictive of clinical protection from malaria. |
Q58752517 | IgG subclass responses to excreted-secreted antigens of Plasmodium falciparum in a low-transmission malaria area of the Peruvian Amazon |
Q26772878 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria |
Q37647647 | Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein in Pregnant Women Are Associated with Higher Birth Weight in a Multicenter Study |
Q54257311 | Proteome-wide mapping of immune features onto Plasmodium protein three-dimensional structures. |
Q30248811 | Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria |
Q37265801 | Safety and immunogenicity of EBA-175 RII-NG Malaria vaccine administered intramuscularly in semi-immune adults: A Phase 1, Double-blinded placebo controlled dosage escalation study |
Search more.